• Home >>
  • Pharmaceuticals and Healthcare >>
  • Assisted Reproductive Technology Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

Assisted Reproductive Technology Global Market Synopsis, Growth Factors, Industry Segmentation, Regional Analysis And Competitive Analysis 2017 - 2025

ID: 231341 May, 2018 Region : Global Pages
Covid-19

COVID-19

Understand the influence of COVID-19 on the Assisted Reproductive Technology Market with our analysts monitoring the situation across the globe.

Assisted Reproductive Technology by Technology (IVF-ET, Artificial Insemination, Surrogacy), by Procedure (frozen donor, frozen non donor, fresh donor) by End-User (fertility clinics, hospitals)-Global Forecast till 2025

Market Synopsis
Assisted Reproductive Technology is used to treat infertility. It comprises variety of medical treatments used to assist conceive and lowers the chances of abnormalities in the ensuing pregnancy. Under this fertility treatment eggs are surgically extracted from female ovaries and are integrated with the laboratory sperms to make embryos. This embryo is again returned to the ovaries of same female or donated to another woman. ART does not only involves the treatment where sperms are handled or pills are taken to trigger the egg production but also over comes fertility problems along with maintaining genetic hereditary. According to CDC’s Fertility Clinic Success Rates Report there were 231,936* ART cycles performed at 464 reporting clinics in the United States during 2015. In current situation, approximately 1.6% of all infants born in the United States every year are conceived using ART.


Rising prevalence of infertility problems and related conditions is the prime factor driving the growth of the assisted reproductive technology market.  According to Maternal Health Task force’s available data at least 50 million couples worldwide experience infertility. Moreover, rising disposable income, growing number of smokers, drastically changed lifestyle causing various disorders such as stress, obesity and many other further drives the growth of the market. The

increasing social acceptance of ART has also lifted the global market which is inclined to witness swift growth in coming future. However, inappropriate of shortfall of rules for practitioners resulting in lower rate of success, expensive treatment, complications associated with the procedure and birth defects risk are the factors that might restrict the market for further growth.  Improving healthcare infrastructure, growing medical tourism due to low treatment cost and rising frequency of fertility treatment options by single parents or same-sex couples consolidate the greater opportunities for the market. However, reduced potency in aged female remains as a big challenge to the market. 


Segmentation
ART market is segmented on the basis of technology, procedures, end-user and geography. 
In terms of technology the market is segregated into in vitro fertilization embryo transfer, artificial insemination, surrogacy and others.
Based on procedure, the market is categorized into frozen donor, frozen non donor, fresh donor, fresh non donor, and embryo banking.
Considering end-user segment the market is divided into fertility clinics, hospitals and others. 


Regional Analysis
Geographically assisted reproductive technology market is segment into Asia-Pacific, North America, Europe and LAMEA. Europe ART market is positively affected owing to government supportive initiatives, increased awareness among people amongst people regarding infertility treatment. Swift adoption of technological advancement, highly improved healthcare infrastructure and increased expanses on healthcare facilities drives the expansion of ART market in North America.  In the United States ages about 10% of women aged between 15-44 face difficulty getting or staying pregnant according to the Centers for Disease Control and Prevention. Market in Asia-Pacific is certainly influenced by growing awareness, developing healthcare sector, late family planning, availability of advanced fertility services and low fertility rate. LAMEA is experiencing sluggish growth in the ART market due to less development in healthcare industry and poor economic condition. 


Key Players
The key players in the ART market include Merck KGaA, Parallabs, IrvineScientific, CooperSurgical, Inc., Ovascience, Cryolab Ltd., Nidacon International AB, Vitrolife AB, Laboratoire CCD and Hamilton Thorne, Inc.,. 


Global Assisted Reproductive Technology Market Segmentation
• By Technology 
o In Vitro Fertilization Embryo Transfer
o Artificial Insemination
o Surrogacy
• By Procedure
o Frozen Donor
o Frozen Non Donor
o Fresh Donor
o Fresh Non Donor
o Embryo Banking
• By End-user
o Fertility-Clinics
o Hospital
o Others
• By Geography
o North America
 U.S.
 Canada
 Mexico
o Europe
 UK
 Germany
 France
 Italy
 Spain
 Rest of Europe
o Asia-Pacific
 China
 India
 Japan
 South Korea
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Saudi Arabia
 South Africa
 Rest of LAMEA 


• Key Market Players
o Merck KGaA
o Parallabs
o IrvineScientific
o CooperSurgical, Inc.
o Ovascience
o Cryolab Ltd.
o Nidacon International AB
o Vitrolife AB
o Laboratoire CCD
o Hamilton Thorne, Inc.

Research Scope
The study for Global Assisted Reproductive Technology Market will provide market size, estimates and forecast based on the following years: 
 
Historic data: 2015  Base Year Estimate: 2016  Forecast: 2017 to 2025


The report has been categorized in two distinctive sections, where the first category titled as Market Overview provides a holistic view of the market, key trends, drivers, challenges/restraints or opportunities with their current and expected impact on the overall industry sales. 
Our analyst implement several qualitative tools such as Ansoff’s Matrix, PESTEL analysis, Porter’s five force analysis among other to interpret and represent key industry findings. 
The second section of the study provides market size, estimates and forecast for key market segments and regional market. The final part of the report highlights key manufacturers/vendors operating in the associated market. 

1. Introduction
1.1. Market Definition
1.2. Market Scope


2. Research Methodology
2.1. Primary Research
2.2. Secondary Sources
2.3. Assumptions & Exclusions


3. Market Overview
3.1. Research Report Segmentation & Scope
3.2. Key Market Trend Analysis
3.2.1. Market Drivers
3.2.2. Market Restraint/Challenges
3.2.3. Market Opportunities
3.3. Porter’s Five Forces Analysis
3.4. Potential Venture Avenues
3.5. Market Share Analysis, 2016 


4. Technology Overview
4.1. Introduction
4.2. Market Size & Forecast, 2015 to 2025
4.2.1. In Vitro Fertilization Embryo Transfer
4.2.2. Artificial Insemination
4.2.3. Surrogacy
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


5. Procedure Overview
5.1. Introduction
5.2. Market Size & Forecast, 2015 to 2025
5.2.1. Frozen Donor
5.2.2. Frozen Non Donor
5.2.3. Fresh Donor
5.2.4. Fresh Non Donor
5.2.5. Embryo Banking
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


6. End-User Overview
6.1. Introduction
6.2. Market Size & Forecast, 2015 to 2025
6.2.1. Fertility-Clinics
6.2.2. Hospital
6.2.3. Others
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


7. Regional Overview
7.1. Introduction
7.2. Market Size & Forecast, 2015 to 2025
7.2.1. North America
7.2.1.1. U.S. 
7.2.1.2. Canada
7.2.1.3. Mexico
7.2.2. Europe
7.2.2.1. UK
7.2.2.2. Germany
7.2.2.3. France
7.2.2.4. Italy 
7.2.2.5. Spain
7.2.2.6. Rest of Europe
7.2.3. Asia-Pacific
7.2.3.1. China
7.2.3.2. India
7.2.3.3. Japan
7.2.3.4. Australia
7.2.3.5. Rest of Asia-Pacific
7.2.4. LAMEA
7.2.4.1. Brazil
7.2.4.2. Saudi Arabia
7.2.4.3. South Africa
7.2.4.4. Rest of LAMEA
 (Note: The segments mentioned above are tentative in nature and are subject to change as the research progresses)


8. Manufacturer/ Vendor Profile
8.1. The following attributes will be considered while profiling key manufacturers in this industry: 
8.1.1. Company Overview
8.1.2. Financial Synopsis
8.1.3. Recent Developments
8.1.4. R&D Investments (if any)
8.1.5. Strategy Overview (Analyst Perspective)
8.1.6. Product Portfolio
8.2. Companies Profiled
8.2.1. Merck KGaA
8.2.2. Parallabs
8.2.3. IrvineScientific
8.2.4. CooperSurgical, Inc.
8.2.5. Ovascience
8.2.6. Cryolab Ltd.
8.2.7. Nidacon International AB
8.2.8. Vitrolife AB
8.2.9. Laboratoire CCD
8.2.10. Hamilton Thorne, Inc.
 (Note: The companies mentioned above are tentative in nature, and profiles of other market players not listed here can be included on request.)

Request COVID-19 Impact Analysis

We understand the economic repercussions of the pandemic and are dedicated towards helping our clients strategize with rapidly changing market scenario,
• Impact of COVID on supply/demand scenario, trade landscape & supply chain
• How market participants are preparing/strategizing to combat the impact
• How does the short-term & long-term scenario for Assisted Reproductive Technology Market looks like

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Sample

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Request Discount

Name*

Email*

Phone*

Name of the Company*

Title/ Designation*

Select Country*

How can we help you?

Related Reports




4 + 6 =

 

Get 15 minutes of free Consultation When you request a Sample Report!

24/7 Research Report

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone:

+1 513 549 5911 (US)

+44 203 318 2846 (UK)

Email: [email protected]

Report ID :231341

Published Date :May, 2018

Category :Pharmaceuticals and Healthcare

Pages : Pages

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports

  • Data Security
  • Your data is safe and secure

  • Vast Report Database
  • We have more than 2 Million reports in our database

  • Client Focused
  • Personalized updates and 24*7 support

  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support

  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie

  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports


Every Sample Will Help to Understand

  • Report Structure and Outline
  • Detailed Table of Content (Including List of Tables and Figures)
  • Research Methodology